09969 Stock: Price, Forecast, Financials & AI Analysis

Loading chart...

High

14.180

Open

13.740

VWAP

13.81

Vol

7.08M

Mkt Cap

Low

13.550

Amount

97.81M

EV/EBITDA(TTM)

31.35

Total Shares

19.56B

EV/OCF(TTM)

233.12

P/S(TTM)

18.97

Events Timeline

No data

News

7.0

01-29aastocks

INNOCARE Anticipates First-Time NP of RMB633M Last Year, with Total Operating Revenue Projected to Increase by 134%

9.0

2025-12-23Globenewswire

InnoCare Pharma Receives IND Approval for Phase II Trial of ICP-488 in CLE

9.0

2025-12-23Yahoo Finance

InnoCare Pharma Receives IND Approval for Phase II Trial of ICP-488 for CLE Treatment

7.5

2025-12-15Globenewswire

Zenas Acquires Global Rights for Orelabrutinib, Enhancing Multiple Sclerosis Treatment Potential

7.5

2025-12-15Newsfilter

Zenas Acquires Global Rights for Orelabrutinib, Enhancing Multiple Sclerosis Treatment Potential

9.0

2025-12-14Globenewswire

InnoCare's Orelabrutinib Phase IIb Trial Achieves Primary Endpoint in SLE Patients

0 Analyst Rating

Wall Street analysts forecast 09969 stock price to rise

0 Buy

0 Hold

0 Sell

Current: 0.000

Low

Averages

High

Current: 0.000

Low

Averages

High

G Sachs

Buy

maintain

AI Analysis

2026-03-30

Reason

G Sachs

Price Target

AI Analysis

2026-03-30

maintain

Buy

Reason

G Sachs has maintained a 'Buy' rating on INNOCARE due to the company's strong sales performance, particularly a 27% year-over-year increase in Orelabrutinib sales in Q4, and an expected 41% increase in sales for 2025. The company is projected to achieve profitability in 2025, two years earlier than anticipated, and management is confident in maintaining profitability through 2026-2027. Although net profit forecasts for 2026-2028 have been slightly revised down due to increased R&D expenses, the overall outlook remains positive.

UBS

Buy

downgrade

2026-03-26

Reason

UBS

Price Target

2026-03-26

downgrade

Buy

Reason

UBS has lowered its sales forecasts for INNOVENT BIOLOGICS for 2026 and 2027 due to performance in the second half of last year, while also raising its expense forecasts. This led to a downward revision of EPS forecasts for those years. Despite these adjustments, the target price was lowered slightly, but the firm maintains a 'Buy' rating.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for 09969

Unlock Now

Valuation Metrics

The current forward P/E ratio for (09969.HK) is -498.68, compared to its 5-year average forward P/E of -152.69. For a more detailed relative valuation and DCF analysis to assess 's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-152.69

Current PE

-498.68

Overvalued PE

358.50

Undervalued PE

-663.88

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

-32.24

Current EV/EBITDA

-77.31

Overvalued EV/EBITDA

20.07

Undervalued EV/EBITDA

-84.56

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

13.68

Current PS

10.72

Overvalued PS

18.80

Undervalued PS

8.57

Financials

AI Analysis

Annual

Quarterly

Whales Holding 09969

Trading Trends

People Also Watch

Frequently Asked Questions

What is (09969) stock price today?

The current price of 09969 is 13.83 USD — it has increased 0.8

What is (09969)'s business?

What is the price predicton of 09969 Stock?

Wall Street analysts forecast 09969 stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for 09969 is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is (09969)'s revenue for the last quarter?

revenue for the last quarter amounts to NaN USD, decreased

What is (09969)'s earnings per share (EPS) for the last quarter?

. EPS for the last quarter amounts to USD, decreased

How many employees does (09969). have?

(09969) has 0 emplpoyees as of May 09 2026.

What is (09969) market cap?

Today 09969 has the market capitalization of 0.00 USD.

09969 Overview

09969 Overview

Events Timeline

No data

News

Valuation Metrics

Forward PE

Forward EV/EBITDA

Forward PS

Financials

Whales Holding 09969

Trading Trends

People Also Watch

Frequently Asked Questions

What is (09969) stock price today?

What is (09969)'s business?

What is the price predicton of 09969 Stock?

What is (09969)'s revenue for the last quarter?

What is (09969)'s earnings per share (EPS) for the last quarter?

How many employees does (09969). have?

What is (09969) market cap?